Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101


Hemodynamic Stability During Prolonged Intermittent Renal Replacement Therapy-Time to Chill Out.

Finkel KW.

Crit Care Med. 2019 Feb;47(2):302-303. doi: 10.1097/CCM.0000000000003509. No abstract available.


Extracorporeal Removal of Light Chains: New Data and Continued Controversies.

Finkel KW, Gallieni M.

Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1753-1754. doi: 10.2215/CJN.05100418. Epub 2018 Oct 22. No abstract available.


Rates for HEDIS Screening for Diabetic Nephropathy Quality Measure May Be Overstated.

Krause TM, Ganduglia-Cazaban C, Finkel KW.

Manag Care. 2018 Aug;27(8):45-49.


Risk Predictors for Postcontrast Acute Kidney Injury.

Krause TM, Ukhanova M, Lee Revere F, Finkel KW.

J Am Coll Radiol. 2018 Nov;15(11):1547-1552. doi: 10.1016/j.jacr.2018.04.015. Epub 2018 May 22.


Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.

Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, Kashani K, Szerlip HM, Prowle JR, Bihorac A, Finkel KW, Zarbock A, Forni LG, Lynch SJ, Jensen J, Kroll S, Chawla LS, Tidmarsh GF, Bellomo R; Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3) Investigators.

Crit Care Med. 2018 Jun;46(6):949-957. doi: 10.1097/CCM.0000000000003092.


Visualization of West Nile Virus in Urine Sediment using Electron Microscopy and Immunogold up to Nine Years Postinfection.

Murray KO, Kolodziej S, Ronca SE, Gorchakov R, Navarro P, Nolan MS, Podoll A, Finkel K, Mandayam S.

Am J Trop Med Hyg. 2017 Dec;97(6):1913-1919. doi: 10.4269/ajtmh.17-0405. Epub 2017 Oct 19.


Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety.

Busse LW, Wang XS, Chalikonda DM, Finkel KW, Khanna AK, Szerlip HM, Yoo D, Dana SL, Chawla LS.

Crit Care Med. 2017 Aug;45(8):1285-1294. doi: 10.1097/CCM.0000000000002441. Review.


Paraprotein-Related Kidney Disease: Attack of the Killer M Proteins.

Perazella MA, Finkel KW; American Society of Nephrology Onco-Nephology Forum.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2256-2259.


5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.

Kerk SA, Finkel KA, Pearson AT, Warner KA, Zhang Z, Nör F, Wagner VP, Vargas PA, Wicha MS, Hurt EM, Hollingsworth RE, Tice DA, Nör JE.

Clin Cancer Res. 2017 May 15;23(10):2516-2527. doi: 10.1158/1078-0432.CCR-16-1834. Epub 2016 Oct 25.


Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology.

Fabbrini P, Finkel K, Gallieni M, Capasso G, Cavo M, Santoro A, Pasquali S.

J Nephrol. 2016 Dec;29(6):735-746. Epub 2016 Oct 18. Review.


Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.

Finkel KW, Cohen EP, Shirali A, Abudayyeh A; American Society of Nephrology Onco-Nephrology Forum.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2273-2279. Epub 2016 Aug 15.


IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.

Finkel KA, Warner KA, Kerk S, Bradford CR, McLean SA, Prince ME, Zhong H, Hurt EM, Hollingsworth RE, Wicha MS, Tice DA, Nör JE.

Neoplasia. 2016 May;18(5):273-281. doi: 10.1016/j.neo.2016.03.004. Epub 2016 Apr 15.


Patient-derived xenograft (PDX) tumors increase growth rate with time.

Pearson AT, Finkel KA, Warner KA, Nör F, Tice D, Martins MD, Jackson TL, Nör JE.

Oncotarget. 2016 Feb 16;7(7):7993-8005. doi: 10.18632/oncotarget.6919.


Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.

O'Hayre M, Inoue A, Kufareva I, Wang Z, Mikelis CM, Drummond RA, Avino S, Finkel K, Kalim KW, DiPasquale G, Guo F, Aoki J, Zheng Y, Lionakis MS, Molinolo AA, Gutkind JS.

Oncogene. 2016 Jul 21;35(29):3771-80. doi: 10.1038/onc.2015.442. Epub 2015 Nov 30.


A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury.

Tumlin JA, Galphin CM, Tolwani AJ, Chan MR, Vijayan A, Finkel K, Szamosfalvi B, Dev D, DaSilva JR, Astor BC, Yevzlin AS, Humes HD; SCD Investigator Group.

PLoS One. 2015 Aug 5;10(8):e0132482. doi: 10.1371/journal.pone.0132482. eCollection 2015.


Biomarker Enhanced Risk Prediction for Adverse Outcomes in Critically Ill Patients Receiving RRT.

Pike F, Murugan R, Keener C, Palevsky PM, Vijayan A, Unruh M, Finkel K, Wen X, Kellum JA; Biological Markers for Recovery of Kidney (BioMaRK) Study Investigators.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1332-9. doi: 10.2215/CJN.09911014. Epub 2015 Jun 5.


Associations between Intensity of RRT, Inflammatory Mediators, and Outcomes.

Murugan R, Wen X, Keener C, Pike F, Palevsky PM, Unruh M, Finkel K, Vijayan A, Elder M, Chen YF, Kellum JA; Biological Markers of Recovery for the Kidney (BioMaRK) Study Investigators.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):926-33. doi: 10.2215/CJN.04560514. Epub 2015 Apr 10.


Prevention of acute kidney injury using vasoactive or antiplatelet treatment: three strikes and out?

Winkelmayer WC, Finkel KW.

JAMA. 2014 Dec 3;312(21):2221-2. doi: 10.1001/jama.2014.14548. No abstract available.


Onco-nephrology: an invitation to a new field.

Finkel KW, Howard SC.

J Clin Oncol. 2014 Aug 1;32(22):2389-90. doi: 10.1200/JCO.2014.56.5622. Epub 2014 Jun 16. No abstract available.


Treatment of acute kidney injury with cast nephropathy.

Walther C, Podoll AS, Finkel KW.

Clin Nephrol. 2014 Jul;82(1):1-6. doi: 10.5414/CN108293. Review.


Is high cut-off hemodialysis effective in myeloma kidney?

Finkel KW.

Semin Dial. 2014 May-Jun;27(3):234-6. doi: 10.1111/sdi.12210. Epub 2014 Mar 25. Review. No abstract available.


Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy.

Murugan R, Wen X, Shah N, Lee M, Kong L, Pike F, Keener C, Unruh M, Finkel K, Vijayan A, Palevsky PM, Paganini E, Carter M, Elder M, Kellum JA; Biological Markers for Recovery of Kidney (BioMaRK) Study Investigators.

Nephrol Dial Transplant. 2014 Oct;29(10):1854-64. doi: 10.1093/ndt/gfu051. Epub 2014 Mar 11.


Summary of clinical practice guidelines for acute kidney injury.

Walther CP, Podoll AS, Finkel KW.

Hosp Pract (1995). 2014 Feb;42(1):7-14. doi: 10.3810/hp.2014.02.1086. Review.


Incidence and outcome of early acute kidney injury in critically-ill trauma patients.

Podoll AS, Kozar R, Holcomb JB, Finkel KW.

PLoS One. 2013 Oct 17;8(10):e77376. doi: 10.1371/journal.pone.0077376. eCollection 2013.


Myoglobin removal using high-volume high-flux hemofiltration in patients with oliguric acute kidney injury.

Guzman N, Podoll AS, Bell CS, Finkel KW.

Blood Purif. 2013;36(2):107-11. doi: 10.1159/000354727. Epub 2013 Sep 25.


Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma.

Warner KA, Adams A, Bernardi L, Nor C, Finkel KA, Zhang Z, McLean SA, Helman J, Wolf GT, Divi V, Queimado L, Kaye FJ, Castilho RM, Nör JE.

Oral Oncol. 2013 Nov;49(11):1059-66. doi: 10.1016/j.oraloncology.2013.08.004. Epub 2013 Sep 12.


Clinical utility of gray scale renal ultrasound in acute kidney injury.

Podoll A, Walther C, Finkel K.

BMC Nephrol. 2013 Sep 8;14:188. doi: 10.1186/1471-2369-14-188.


The effect of the selective cytopheretic device on acute kidney injury outcomes in the intensive care unit: a multicenter pilot study.

Tumlin JA, Chawla L, Tolwani AJ, Mehta R, Dillon J, Finkel KW, DaSilva JR, Astor BC, Yevzlin AS, Humes HD.

Semin Dial. 2013 Sep-Oct;26(5):616-23. doi: 10.1111/sdi.12032. Epub 2012 Oct 29.


Liver support systems--a review.

Podoll AS, DeGolovine A, Finkel KW.

ASAIO J. 2012 Sep-Oct;58(5):443-9. doi: 10.1097/MAT.0b013e31825f3446. Review.


Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort.

Nolan MS, Podoll AS, Hause AM, Akers KM, Finkel KW, Murray KO.

PLoS One. 2012;7(7):e40374. doi: 10.1371/journal.pone.0040374. Epub 2012 Jul 6.


Relationship between bispectral index values and volatile anesthetic concentrations during the maintenance phase of anesthesia in the B-Unaware trial.

Whitlock EL, Villafranca AJ, Lin N, Palanca BJ, Jacobsohn E, Finkel KJ, Zhang L, Burnside BA, Kaiser HA, Evers AS, Avidan MS.

Anesthesiology. 2011 Dec;115(6):1209-18. doi: 10.1097/ALN.0b013e3182395dcb.


Evaluation of pre-procedure ultrasound examination as a screening tool for difficult spinal anaesthesia*.

Weed JT, Taenzer AH, Finkel KJ, Sites BD.

Anaesthesia. 2011 Oct;66(10):925-30. doi: 10.1111/j.1365-2044.2011.06834.x. Epub 2011 Jul 25.


Urinary biomarkers and renal recovery in critically ill patients with renal support.

Srisawat N, Wen X, Lee M, Kong L, Elder M, Carter M, Unruh M, Finkel K, Vijayan A, Ramkumar M, Paganini E, Singbartl K, Palevsky PM, Kellum JA.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1815-23. doi: 10.2215/CJN.11261210. Epub 2011 Jul 14.


Spinal anesthesia for orthopedic surgery: a detailed video assessment of quality.

Weed J, Finkel K, Beach ML, Granger CB, Gallagher JD, Sites BD.

Reg Anesth Pain Med. 2011 Jan-Feb;36(1):51-5. doi: 10.1097/AAP.0b013e3182030863.


Bispectral index monitoring, duration of bispectral index below 45, patient risk factors, and intermediate-term mortality after noncardiac surgery in the B-Unaware Trial.

Kertai MD, Palanca BJ, Pal N, Burnside BA, Zhang L, Sadiq F, Finkel KJ, Avidan MS; B-Unaware Study Group.

Anesthesiology. 2011 Mar;114(3):545-56. doi: 10.1097/ALN.0b013e31820c2b57.


Transitions from neonatal intensive care unit to ambulatory care: description and evaluation of the proactive risk assessment process.

Moyer VA, Singh H, Finkel KL, Giardino AP.

Qual Saf Health Care. 2010 Oct;19 Suppl 3:i26-30. doi: 10.1136/qshc.2010.040543.


Hospital-acquired acute kidney injury.

Finkel KW, Podoll AS.

Hosp Pract (1995). 2009 Dec;37(1):98-106. doi: 10.3810/hp.2009.12.260. Review.


Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality in critically ill patients with cancer.

Samuels J, Ng CS, Nates J, Price K, Finkel K, Salahudeen A, Shaw A.

Support Care Cancer. 2011 Oct;19(10):1527-32. doi: 10.1007/s00520-010-0978-7. Epub 2010 Aug 15.


Association of perioperative risk factors and cumulative duration of low bispectral index with intermediate-term mortality after cardiac surgery in the B-Unaware Trial.

Kertai MD, Pal N, Palanca BJ, Lin N, Searleman SA, Zhang L, Burnside BA, Finkel KJ, Avidan MS; B-Unaware Study Group.

Anesthesiology. 2010 May;112(5):1116-27. doi: 10.1097/ALN.0b013e3181d5e0a3.


Discontinuation of continuous renal replacement therapy: when is enough enough?

Finkel KW, Podoll AS.

Crit Care Med. 2009 Sep;37(9):2664-5. doi: 10.1097/CCM.0b013e3181abfc4b. No abstract available.


Complications of continuous renal replacement therapy.

Finkel KW, Podoll AS.

Semin Dial. 2009 Mar-Apr;22(2):155-9. doi: 10.1111/j.1525-139X.2008.00550.x. Review.


Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center.

Finkel KJ, Searleman AC, Tymkew H, Tanaka CY, Saager L, Safer-Zadeh E, Bottros M, Selvidge JA, Jacobsohn E, Pulley D, Duntley S, Becker C, Avidan MS.

Sleep Med. 2009 Aug;10(7):753-8. doi: 10.1016/j.sleep.2008.08.007. Epub 2009 Jan 30.


Nutritional status and mortality of critically ill patients with acute kidney injury.

Finkel KW, Podoll AS.

Crit Care Med. 2008 Dec;36(12):3259-60. doi: 10.1097/CCM.0b013e318187b753. No abstract available.


Intensity of renal support in critically ill patients with acute kidney injury.

VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P.

N Engl J Med. 2008 Jul 3;359(1):7-20. doi: 10.1056/NEJMoa0802639. Epub 2008 May 20. Erratum in: N Engl J Med. 2009 Dec 10;361(24):2391.


Lessons for successful study enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study.

Crowley ST, Chertow GM, Vitale J, O'Connor T, Zhang J, Schein RM, Choudhury D, Finkel K, Vijayan A, Paganini E, Palevsky PM; VA/NIH Acute Renal Failure Trial Network Study Group.

Clin J Am Soc Nephrol. 2008 Jul;3(4):955-61. doi: 10.2215/CJN.05621207. Epub 2008 Apr 2.


Anesthesia awareness and the bispectral index.

Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman AC, Selvidge JA, Saager L, Turner MS, Rao S, Bottros M, Hantler C, Jacobsohn E, Evers AS.

N Engl J Med. 2008 Mar 13;358(11):1097-108. doi: 10.1056/NEJMoa0707361.


Efficacy and safety of renal tubule cell therapy for acute renal failure.

Tumlin J, Wali R, Williams W, Murray P, Tolwani AJ, Vinnikova AK, Szerlip HM, Ye J, Paganini EP, Dworkin L, Finkel KW, Kraus MA, Humes HD.

J Am Soc Nephrol. 2008 May;19(5):1034-40. doi: 10.1681/ASN.2007080895. Epub 2008 Feb 13.


Renal disease in patients with cancer.

Finkel KW, Foringer JR.

Nat Clin Pract Nephrol. 2007 Dec;3(12):669-78. Review.


Acute phenol poisoning: a life-threatening hazard of chronic pain relief.

Gupta S, Ashrith G, Chandra D, Gupta AK, Finkel KW, Guntupalli JS.

Clin Toxicol (Phila). 2008 Mar;46(3):250-3.


Pegylated liposomal doxorubicin treatment in recurrent gynecologic cancer patients with renal dysfunction.

Li Y, Finkel KW, Hu W, Fu S, Liu J, Coleman R, Kavanagh JJ.

Gynecol Oncol. 2007 Aug;106(2):375-80. Epub 2007 May 18.


Supplemental Content

Loading ...
Support Center